---
title: 'Management of patients with rare adult solid cancers: objectives and evaluation
  of European reference networks (ERN) EURACAN'
date: '2024-02-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38384730/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240222170805&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: About 500,000 patients with rare adult solid cancers (RASC) are diagnosed
  yearly in Europe. Delays and unequal quality of management impact negatively their
  survival. Since 2017, European reference networks (ERN) aim to improve the quality
  of care of patients with rare disease. The steering committee of EURACAN, including
  physicians, researchers and patients review here the previous actions, present objectives
  of the ERN EURACAN dedicated to RASC. EURACAN promoted management in ...
disable_comments: true
---
About 500,000 patients with rare adult solid cancers (RASC) are diagnosed yearly in Europe. Delays and unequal quality of management impact negatively their survival. Since 2017, European reference networks (ERN) aim to improve the quality of care of patients with rare disease. The steering committee of EURACAN, including physicians, researchers and patients review here the previous actions, present objectives of the ERN EURACAN dedicated to RASC. EURACAN promoted management in ...